Avestar Capital’s NuVasive, Inc. NUVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-4,792
Closed -$251K 495
2021
Q4
$251K Buy
4,792
+957
+25% +$52K 0.03% 389
2021
Q3
$230K Buy
3,835
+645
+20% +$39.8K 0.03% 403
2021
Q2
$216K Buy
+3,190
New +$218K 0.03% 410

Other funds holding NUVA

Avestar Capital's NUVA Position: Q1 2022 in Review

Avestar Capital sold out of NuVasive, Inc. (NUVA) in Q1 2022, closing a stake of 4,792 shares — an estimated $251K sold.

Avestar Capital first reported a position in NUVA in Q2 2021 and held it in 3 quarters. The position peaked at $251K in Q4 2021. 245 funds tracked by Wall St. Rank hold NUVA as of Q1 2022.

  • Avestar Capital reported no remaining NuVasive, Inc. position as of Q1 2022 after selling out during the quarter.
  • Avestar Capital sold 4,792 NuVasive, Inc. shares in Q1 2022, an estimated $251K.
  • Avestar Capital first reported a position in NuVasive, Inc. in Q2 2021 and held it in 3 quarters.
  • Avestar Capital's NuVasive, Inc. position peaked at $251K in Q4 2021.
  • 245 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q1 2022.

Based on Avestar Capital's 13F filing for Q1 2022, filed 26 Apr 2022.